MT 81

Drug Profile

MT 81

Latest Information Update: 17 Apr 1997

Price : $50

At a glance

  • Originator Jadavpur University
  • Class Anthraquinones; Antibacterials; Antiprotozoals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 17 Apr 1997 No-Development-Reported for Bacterial infections in India (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top